IFNG and neoplasm: PD-L1 expression in tumor is constitutively upregulated by oncogene alterations, such as PD-L1 and JAK2 genomic amplification or PI3K/AKT pathway activation, and is induced by the interferon gamma (IFN-γ) generated by infiltrating lymphocytes [73,74,75,76].